However, it is almost impossible to expect that TNF-α or TRAIL can accumulate to a concentration high enough to kill tumor cells in vivo, let alone determine the relationship of TNF-α level in patients and prognosis. The gene discussed is TNFSF10; the disease is neoplasm.